Sundrug Co.,Ltd. (TYO:9989)
4,311.00
+114.00 (2.72%)
Feb 19, 2025, 3:30 PM JST
Sundrug Revenue
Sundrug had revenue of 208.01B JPY in the quarter ending December 31, 2024, with 7.07% growth. This brings the company's revenue in the last twelve months to 789.40B, up 7.13% year-over-year. In the fiscal year ending March 31, 2024, Sundrug had annual revenue of 751.78B with 8.88% growth.
Revenue (ttm)
789.40B
Revenue Growth
+7.13%
P/S Ratio
0.64
Revenue / Employee
118.49M
Employees
6,662
Market Cap
502.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 751.78B | 61.32B | 8.88% |
Mar 31, 2023 | 690.46B | 41.73B | 6.43% |
Mar 31, 2022 | 648.73B | 14.42B | 2.27% |
Mar 31, 2021 | 634.31B | 16.54B | 2.68% |
Mar 31, 2020 | 617.77B | 29.70B | 5.05% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |